Guidelines of care for the management of cutaneous squamous cell carcinoma.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 29331386.
- Also identified by DOI 10.1016/j.jaad.2017.10.007 and PMC identifier 6652228.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human cancer and has an increasing annual incidence. Although most cSCC is cured with office-based therapy, advanced cSCC poses a significant risk for morbidity, impact on quality of life, and death. This document provides evidence-based recommendations for the management of patients with cSCC. Topics addressed include biopsy techniques and histopathologic assessment, tumor staging, surgical and nonsurgical management, follow-up and prevention of recurrence, and management of advanced disease. The primary focus of these recommendations is on evaluation and management of primary cSCC and localized disease, but where relevant, applicability to recurrent cSCC is noted, as is general information on the management of patients with metastatic disease.
Medical subject headings
- Antineoplastic Agents
- Carcinoma, Squamous Cell
- Dermatologic Surgical Procedures
- Neoplasms, Second Primary
- Skin Neoplasms